Home
Biogen BIIB spent $830K on lobbying in Q2 2023 · Health Issues, Medicare and 5 more issues
Trade details
- Type
- Lobbying report
- Amount
- $830,000
- Quarter
- Q2 2023
- Stock
- Biogen BIIB
- Client
- Biogen
- Reported
- 23/07/20
Down 16.2% from last quarter
What else happened in Biogen around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Biogen's other lobbying reports
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$1.1M
$1.1M
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$60K
$60K
Reported 07/20
for Q2
- Biogen
LobbyingBiogen
LobbyingBiogen
BIIB
$50K
$50K
Reported 04/20
for Q1